Real Research, Real Results. Together We Can Cure Cancer.
The Sbarro Health Research Organization (SHRO) is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Institute with a generous donation from Mario Sbarro, the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2. Initially named the Sbarro Institute, the research center was located at Thomas Jefferson University, where Dr. Giordano was a professor.

Message from Dr. Antonio Giordano – Founder of SHRO
“Think of genetic research as language. We have identified the words; now we are constructing the dictionary and learning the rules of grammar. Our task is to continue assembling the dictionary and perhaps the construction of a few grammatically accurate sentences. The goal is to eventually add new chapters to the novel of life”
Latest Posts
“If I have seen further it is by standing on the shoulders of Giants” – Sir Isaac Newton (in…
Read More
Researchers Call for More Transparency from Russia’s Sputnik COVID Vaccine
Alisha
/ August 15, 2021
“It is not a problem connected to “the Sputnik V” vaccine itself,” argues Prof. Enrico Bucci, adjunct professor in the…
Read More
SHRO’s Giordano Meets with Speaker Pelosi at Italian Embassy in Washington
Alisha
/ August 15, 2021
Newswise — WASHINGTON, D.C. May 19, 2021—At the prestigious setting of Villa Firenze, the Italian Embassy in Washington, DC, on…
Read More
Inflammation and Procalcitonin Predict Success, or Not, of Lung Cancer Treatment
Alisha
/ August 15, 2021
In patients with non-small cell Lung Cancer (NSCLC), the presence of either high chronic inflammation, or procalcitonin levels in the…
Read More
The Medicine in Eye Drops Needs a Disguise to Sneak Past Your Tears
Alisha
/ August 15, 2021
Scientists use engineered protein coating that binds to receptors on the surface of corneal cells to improve drug uptake. The…
Read More